SKU: C078  / 
    CAS Number: 42540-40-9

    Cefamandole Nafate, USP

    $605.88 - $1,108.08
    • Detailed Description
    • Applications

      Spectrum: Cefamandole is a broad-spectrum cephalosporin targeting a wide variety of Gram-positive and Gram- negative bacteria.

      Microbiology Applications:

      Cefamandole Nafate is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against Gram-positive and Gram-negative microbial isolates. Medical microbiologists use AST results to recommend antibiotic treatment options.

      Representative MIC values include:

      • Escherichia coli 0.08 µg/mL – 100 µg/mL
      • Klebsiella pneumoniae 0.8 µg/mL – 12.5 µg/mL
      • For a complete list of Cefamandole MIC values, click here.

    • Specifications

      Form: Powder

      Appearance: White or almost white powder

      Source: Semi-synthetic

      Water Content (Karl Fischer): ≤2.0%

      pH: 3.5-7.0

      Assay: (On Dried Basis): 810-1000µg/mg

      Identification: HPLC, IR, UV, Flame reaction of Na

    • Technical Data

      Solubility: Methanol: Sparingly soluble
      Water: Soluble

      Impurity Profile: |Cefamandole nafate|42540-40-9|C19H17N6NaO6S2|512.5| |Cefamandole sodium|30034-03-8|C18H17NaO5S2|484.5| Impurity A| formylmandeloyl-7-amino-desacetoxy-cephalosporanic acid||C16H16N2O6S|364.4| Impurity C| O-acetylcefamandole||C18H20N6O6S2|480.5| Impurity D| 1-methyl-1H-tetrazole-5-thiol|69713-31-1|C2H4N4S|16.145| Impurity E| formylmandeloyl-7-ACA||C19H18N2O8S|434.4|

    • References

      References:

      Georgopapadakou NH (1992)  Mechanisms of action of Cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.  Antimicrob. Agents Chemother. 37(3):559-565. 

      Gupta D, V, Stewart KR (1981)  Stability of Cefamandole Nafate and cefoxitin sodium solutions. Am. J. Hosp. Pharm. 38(6):875-879  PMID 7246563

    Cefamandole Nafate, USP is a second-generation cephalosporin and beta-lactam antibiotic with bactericidal activity.  It is  freely soluble in aqueous solution and sparingly soluble in methanol.  The ester compound, Nefamandole Nafate is hydrolyzed to Cefamandole.

    Cefamandole has been used to study the expression of penicillin-binding proteins on bacterial cell walls and antibiotic resistance mechanisms.

    We also offer:

    • Cefamandole Sodium (C079)

    Spectrum: Cefamandole is a broad-spectrum cephalosporin targeting a wide variety of Gram-positive and Gram- negative bacteria.

    Microbiology Applications:

    Cefamandole Nafate is commonly used in clinical in vitro microbiological antimicrobial susceptibility tests (panels, discs, and MIC strips) against Gram-positive and Gram-negative microbial isolates. Medical microbiologists use AST results to recommend antibiotic treatment options.

    Representative MIC values include:

    • Escherichia coli 0.08 µg/mL – 100 µg/mL
    • Klebsiella pneumoniae 0.8 µg/mL – 12.5 µg/mL
    • For a complete list of Cefamandole MIC values, click here.

    Form: Powder

    Appearance: White or almost white powder

    Source: Semi-synthetic

    Water Content (Karl Fischer): ≤2.0%

    pH: 3.5-7.0

    Assay: (On Dried Basis): 810-1000µg/mg

    Identification: HPLC, IR, UV, Flame reaction of Na

    Solubility: Methanol: Sparingly soluble
    Water: Soluble

    Impurity Profile: |Cefamandole nafate|42540-40-9|C19H17N6NaO6S2|512.5| |Cefamandole sodium|30034-03-8|C18H17NaO5S2|484.5| Impurity A| formylmandeloyl-7-amino-desacetoxy-cephalosporanic acid||C16H16N2O6S|364.4| Impurity C| O-acetylcefamandole||C18H20N6O6S2|480.5| Impurity D| 1-methyl-1H-tetrazole-5-thiol|69713-31-1|C2H4N4S|16.145| Impurity E| formylmandeloyl-7-ACA||C19H18N2O8S|434.4|

    References:

    Georgopapadakou NH (1992)  Mechanisms of action of Cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.  Antimicrob. Agents Chemother. 37(3):559-565. 

    Gupta D, V, Stewart KR (1981)  Stability of Cefamandole Nafate and cefoxitin sodium solutions. Am. J. Hosp. Pharm. 38(6):875-879  PMID 7246563